Document is current

Any future updates will be listed below

Does the low prevalence affect the sample size of interventional clinical trials of rare diseases? An analysis of data from the aggregate analysis of clinicaltrials.gov

Crossref DOI link: https://doi.org/10.1186/s13023-017-0597-1

Published Online: 2017-03-02

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark